CD3-positive cells were enhanced by trend in the areas of tumors treated with ascorbate or anti-PD1, whereas the combination resulted in a significant rise in these cells in line with increased immune cell infiltration into the tumor (Figure 5E,H). Here, PDCD1 is linked to neoplasm.